Study: Anti-Inflammatory Therapies Could Reduce Heart Disease Risk in Elderly Patients With Clonal Hematopoiesis – Pharmacy Times
stemadminStem Cell ResearchNo comments

Anti-inflammatory therapies could be effective at preventing heart disease in patients with clonal hematopoiesis, a common age-related blood condition, according to a new study published in Nature. The researchers identified how clonal hematopoiesis worsens atherosclerosis, and their findings suggest that an anti-inflammatory drug previously tested in a broader population of patients with cardiovascular disease may have potential for patients with atherosclerotic heart disease and clonal hematopoiesis. Thought to occur in roughly 10% of people over 70 years of age, clonal hematopoiesis occurs when hematopoietic stem cells (HSCs) acquire mutations.

Read more
Can This New Electrophysiology Technology Boost Neurology Research? – Labiotech.eu
stemadminStem Cell ResearchNo comments

An emerging new electrophysiology technology, known as high-density microelectrode arrays, enables researchers to study in vitro models of human brain disease in detail. This creates new possibilities to understand the underlying mechanisms of neurological disorders, like Parkinsons disease and amyotrophic lateral sclerosis, and advance therapy development

Read more
Stem Cell Characterization and Analysis ToolMarket Size, Share, Industry Analysis, Forecast and Global Research Report to 2027 – The Market Eagle
stemadminStem Cell ResearchNo comments

Introduction and scope: Stem Cell Characterization and Analysis Tool Market A comprehensive valuation study conducted for the Stem Cell Characterization and Analysis Tool market report reveals future growth prospects, trends, drivers and restraints, challenges, and opportunities. The market report presents a holistic approach in which statistical, analytical, historical, and economic data are exchanged.

Read more
Researchers describe the systems that manage embryonic stem cells – Microbioz India
stemadminStem Cell ResearchNo comments

Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muoz, have clarified the mechanisms, unknown to date, included in maintaining embryonic stem cells in the best possible condition for their use in regenerative medicine. The results, published in Nature Communications, helps to find novel stem-cell therapies for brain stroke, heart disease or neurodegenerative conditions like Alzheimers or Parkinsons disease.

Read more
Cell therapy player Fate Therapeutics sees CSO and 12-year veteran Shoemaker retire – FierceBiotech
stemadminStem Cell ResearchNo comments

Fate Therapeutics long-standing Chief Scientific Officer Daniel Shoemaker, Ph.D., will be leaving the cell therapy biotech this summer. The biotech, which uses an induced pluripotent stem cell (iPSC) platform and is targeting off-the-shelf cell therapies for cancer, says he advised the company that he is retiring as of June 30, 2021, coming off a 12-year stint, spending half that time as its CSO.

Read more
Global Vaccine, Insulin and Stem Cell Market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis 2020-2026 The Bisouv Network…
stemadminStem Cell ResearchNo comments

A SWOT Analysis ofVaccine, Insulin and Stem Cell, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down. The global Vaccine, Insulin and Stem Cell Market report offers a planned observation of analyzed data associated to Vaccine, Insulin and Stem Cell market. The Vaccine, Insulin and Stem Cell market report offers multiple opportunities to various industries, vendors, associations, and organizations offering items and administrations Geron Corporation., Cytori Therapeutics Inc., ImmunoCellular Therapeutics Ltd, Eli Lilly and Company, Novartis AG, Astellas Pharma, Osiris Therapeutics Inc., Aduro biotech, Biocon Ltd., Glaxo SmithKline PLC, Athersys, Ypsomed AG, Sanofi, Novo Nordisk A/S, Merck & CO., Fate Therapeutics Inc., INC.

Read more
Stem cell therapy could help restore debilitating age-related muscle loss – News-Medical.Net
stemadminStem Cell ResearchNo comments

As the name implies, induced pluripotent stem cells can become any type of cell in our body, and scientists have evidence that when they prompt them to become muscle progenitor cells they can help restore the sometimes debilitating muscle loss that happens with age. Progressive, age-related muscle loss is called sarcopenia, and it can impair mobility and quality of life, says Dr. Wanling Xuan, stem cell biologist in the Vascular Biology Center at the Medical College of Georgia

Read more
Cell Culture: Disrupting the Meat Industry – Open Access Government
stemadminStem Cell ResearchNo comments

ORF Genetics is aninnovative plant biotechnology company and apioneer in developing and manufacturing high-quality recombinantproteins, such as growth factors, derived from barley plants. Founded in 2001, it has developed a unique technology, ORFEUS, which uses barley grain as a factory for recombinant protein production, providing a more efficient and safer method than other protein expression systems provide. The barley is grown in ORFs own high-tech, eco-friendly greenhouse, which is isolated in a black lava field on the Reykjanes Peninsula, Iceland, using the countries rich renewable energy resources

Read more
Canine Stem Cell Therapy Market Research and New Developments 2021-2026 KSU | The Sentinel Newspaper – KSU | The Sentinel Newspaper
stemadminStem Cell ResearchNo comments

Global Canine Stem Cell Therapy Market Size, Status and Forecast 2021 The Global Canine Stem Cell Therapy Market Research Report 2021-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable).

Read more

Theme: Illdy.